Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Crixivan 200mg*

Crixivan 200mg* :
Type Medicine Non Marketed
Originator B
Agent Droguerie de l'Union
Distributor Droguerie de l'Union
Laboratory MSD
Responsible Party Merck & Co Inc
Origin U.S.A.
Manufacturer Merck & Co Inc
Origin U.S.A.
ATC J05AE02

Your comment will appear shortly after approval

Crixivan 200mg* :

Revision Date : 11/03/2015


Effect Frequency
Abdominal pain Very Common
Acute kidney injury Not known
Alopecia Not known
ALT increased Very Common
Anaemia Not known
Anaphylactoid reactions Not known
AST increased Very Common
Asthenia Very Common
Autoimmune disorder Not known
Basedow's disease Not known
Blood alkaline phosphatase increased Not known
Blood creatine phosphokinase increased Not known
Blood creatinine increased Not known
Body fat disorder Not known
Crystalluria Very Common
Diabetes mellitus Not known
Diarrhoea (Diarrhea) Very Common
Dizziness Very Common
Dry mouth (Xerostomia) Common
Dry skin Very Common
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Very Common
Dyspepsia Very Common
Dysuria (Micturition painful) Common
Erythema multiforme Not known
Fatigue Very Common
Flank pain Not known
Flatulence Common
Haematuria (Hematuria) Very Common
Haemolytic anemia Not known
Haemorrhagic diathesis Not known
Headache Very Common
Hepatic failure (Hepatic insufficiency) (Liver failure) Not known
Hepatic function abnormal Not known
Hepatitis Not known
Hyperbilirubinaemia Very Common
Hypercholesterolaemia Not known
Hyperglycaemia Not known
Hyperlactacidaemia Not known
Hypersensitivity vasculitis Not known
Hypertriglyceridaemia Not known
Hypoesthesia Common
Immune reconstitution inflammatory syndrome Not known
Ingrowing nail Not known
Insomnia Common
Insulin resistance Not known
Leukocytosis Not known
Lipoatrophy Not known
Lipomatosis Not known
Mean cell volume increased Very Common
Metabolic disorder Not known
Myalgia Common
Myositis Not known
Nausea Very Common
Nephrolithiasis Common
Neutrophil count decreased Very Common
Osteonecrosis Not known
Pancreatitis Not known
Paraesthesia (paresthesia) Common
Paraesthesia oral Not known
Paronychia Not known
Periarthritis Not known
Product deposit Not known
Proteinuria Very Common
Pruritus Common
Pyelonephritis Not known
Pyrexia Not known
Regurgitation Common
Renal failure Not known
Rhabdomyolysis Not known
Skin hyperpigmentation Not known
Skin rash Very Common
Stevens-Johnson syndrome Not known
Thrombocytopenia (Thrombopenia) Not known
Tubulointerstitial nephritis Not known
Urticaria Not known
Vomiting Very Common

Different Units By MoH Code

Revision Date : 01/09/2016

Crixivan 200mg*  MoH 1051 :
Form Capsule, hard
Package Size Box of 360
Strength 200mg
NSSF ✘
Quarantine ✘
Reg. Number 261076
Submission date 01/01/1997
Registration Year 1997
Archived Date 2017


Price Comparison

● Country: Switzerland
● Package Size: 360
● Public Price: 408.6 CHF ( 42,257,412.00 LBP )
● Pack size unit used: 360
● Cost/Unit: 1,135 CHF ( 103,420.00 LBP )
● Exfactory Price: 341.63 CHF
● Pricing Date: 19/07/2017
● Type: Medicine Non Marketed

● Country: Sweden
● Package Size: 360
● Public Price: 2617.86 SEK ( 22,010,966.88 LBP )
● Pack size unit used: 360
● Cost/Unit: 7,2718 SEK ( 58,856.00 LBP )
● Pharmacy Price: 2521.19 SEK ( 21198165.52 LBP )
● Pricing Date: 23/04/2020
● Type: Medicine Authorised

● Country: UK
● Package Size: 360
● Public Price: 181.02 GBP ( 20,572,741.98 LBP )
● Pack size unit used: 360
● Cost/Unit: 0,5028 GBP ( 0.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Withdrawn

● Country: The Netherlands
● Package Size: 360
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Non Marketed

● Country: New Zealand
● Package Size: 360 cap
● Exfactory Price: 519.75 NZD
● Reference: New Zealand Pharmaceutical Management Agency
● Pricing Date: 31/01/2018
● Type: Medicine Non Marketed

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info